Myeloma Proteins
HETEROGENEITY OF MYELOMA PROTEINS
... STARCH GEL ELECTROPHORESIS OF REPRESENTATIVE MYELOMA SERA SHOWING SINGLE COMPONENT MYELOMA PROTEINS SERA 2-6, COUNTING FROM LEFT, ELECTROPHORETIC HETEROGENEITY OF MYELOMA PROTEINS SERA 7[r] ...
14
Thymine and guanine base specificity of human myeloma proteins with anti DNA activity
... human myeloma proteins that bind ...three proteins. A myeloma protein that reacted with poly(G), poly(I), or poly(dT) also bound to the corresponding nucleosides or nucleotides conjugated to ...
7
Catabolism of human γG immunoglobulins of different heavy chain subclasses: I Catabolism of γG myeloma proteins in man
... multiple myeloma. On the average, gG 1 -, gG 2 -, and gG 4 -myeloma proteins were catabolized at a rate similar to that of normal gG-immunoglobulin, whereas gG 3 -myeloma proteins were ...
9
TWO TYPES OF γ MYELOMA PROTEINS, β2A MYELOMA PROTEINS, γ1 MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS
... The demonstration of two separate groups of antigenic determinants, common to all a-globulin groups-i.e., in the y-myeloma proteins, 82A-myeloma proteins, y-macroglobulins, and Bence Jon[r] ...
13
Generation and analysis of clonal IgM and IgG producing human B cell lines expressing an anti DNA associated idiotype
... immunoglobulin V gene utilization in an anti-DNA-associated idiotypic system. The 31 anti- DNA-associated idiotype is encoded preferentially by the VK1 gene family, and, in all probability, reflects a germ line ...
8
Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1.
... To exclude the possibility of a selective inactivation of the IgG3 myeloma proteins by the radioiodination procedure, unlabeled myeloma proteins belonging to different IgG subclasses wer[r] ...
9
Human myeloma IgA half molecules
... IgAl myeloma protein that formed two chain half-molecules was obtained from a patient who had typical multiple ...IgA myeloma proteins but showed a line of identity to their F(ab')2 ...
8
Variations among gamma globulins at the antigenic site revealed by pepsin digestion
... Deficiency of IgG myeloma proteins for the pepsin site occurred in all M-components of the Ge or Ne H-chain subgroup; universal deficiency was not a feature of the Vi myelomas tested, si[r] ...
11
Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils
... human myeloma proteins of different classes and subclasses for lymphocytes, monocytes, and neutrophils was ...IgG3 proteins, but none of the proteins of the other ...IgE proteins bound ...
10
Two distinct groups of immunoglobulin A(IgA) revealed by peptic digestion
... components segregated into two groups on the basis of their relative rates of peptic digestion. Serum and colostral IgA were digested at a total rate intermediate to that of the two groups of IgA myeloma ...
9
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
... The dose, schedule, and route of administration of each drug included in the induction, intensification, and main tenance regimens are described in the appendix (p 3). Briefly, in transplantationeligible patients, ...
14
Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma
... Multiple myeloma (MM) is a malignant neoplasm arising from clonal proliferation of plasma cells in the bone mar- row; MM can cause renal dysfunction through various mechanisms, including paraprotein- or ...
6
Multiple myeloma in the very elderly patient: challenges and solutions
... Prophylactic fluconazole (to prevent candidiasis) and aci- clovir (to prevent herpes simplex and/or zoster) are typically coprescribed with chemotherapy. There is no good evidence for the use of antibacterial prophylaxis ...
13
FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS
... prolong overall survival of the patients (4, 5). since then a lot further research was done and several new drugs have been introduced to the treatment of myeloma patients. especially thalidomide and bortezomib ...
5
A Devil in disguise- An interesting case of Non secretory Multiple myeloma
... Multiple Myeloma represents a malignant proliferation of plasma cells derived from a single clone. The tumor, its products, and the host response to it result in a number of organ dysfunctions and symptoms, ...
6
Original Article Gene expression profiling based on microarray among monoclonal gammopathy of undetermined significance, smoldering multiple myeloma and multiple myeloma
... Multiple myeloma (MM) and smoldering multiple myeloma (SMM) are different types of plasma cell malig- nancy which are believed to be developed from Monoclonal Gammopathy of Undetermined Significance ...
7
Treating myeloma cast nephropathy without treating myeloma
... Cast nephropathy is the result of coprecipitation of immunoglobulin free light chains (FLCs) with Tamm-Horsfall glycoprotein (THP). It is a hall- mark of multiple myeloma that has significant consequences. ...
5
Biology and Treatment of Skeletal Manifestations in Multiple Myeloma
... Multiple myeloma has the highest incidence of skeletal manifestations among malignant haematologic ...includes myeloma-directed chemotherapy, agents inhibiting bone resorption such as aminobisphosphonates ...
16
Bone Marrow Mast Cell Density Correlates with Circulating Biomarkers of Bone Disease in Multiple Myeloma
... MCs accumulation has been associated with enhanced growth and invasion in various human cancers, including breast, stomach, esophagus and oral cavity [26]. There is an increasing study of MCs participation in MM ...
10
Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
... Several groups have been using mass spectrometry based techniques in order to identify potential biomark- ers that are early predictors of cancer development [56- 61]. Elucidation of these early biomarkers for various ...
11